Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03211442Completed

Implications of MEDIcal Low Dose RADiation Exposure - BReast Cancer Acute Coronary Events

Role: collaborator

NCT02605512Not ApplicableCompleted

BreAst Cancer and Cardiotoxicity Induced by RAdioTherapy: the BACCARAT Study

Role: collaborator

NCT03297346Not ApplicableCompleted

Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer

Role: lead

NCT04876287Completed

Salivary dysfuncTion After Radioiodine Treatment

Role: lead

NCT02079272Not ApplicableWithdrawn

REBECCA Study (RadiothErapy for BrEast Cancer and CArdiotoxicity)

Role: collaborator

All 5 trials loaded